These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7521502)

  • 1. Acute respiratory insufficiency during doxorubicin, cyclophosphamide, and G-CSF therapy.
    van Woensel JB; Knoester H; Leeuw JA; van Aalderen WM
    Lancet; 1994 Sep; 344(8924):759-60. PubMed ID: 7521502
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.
    Stute N; Santana VM; Rodman JH; Schell MJ; Ihle JN; Evans WE
    Blood; 1992 Jun; 79(11):2849-54. PubMed ID: 1375115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.
    Nabholtz JM; Cantin J; Chang J; Guevin R; Patel R; Tkaczuk K; Vodvarka P; Lindsay MA; Reese D; Riva A; Mackey J
    Clin Breast Cancer; 2002 Oct; 3(4):268-75. PubMed ID: 12425755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic Lymphohistiocytosis After Initiation of Chemotherapy for Bilateral Adrenal Neuroblastoma.
    Nascimento FA; Nery J; Trennepohl J; Pianovski MA
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e13-5. PubMed ID: 26583611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes.
    Fumoleau P; Chauvin F; Namer M; Bugat R; Tubiana-Hulin M; Guastalla JP; Delozier T; Kerbrat P; Devaux Y; Bonneterre J; Filleul A; Clavel M
    J Clin Oncol; 2001 Feb; 19(3):612-20. PubMed ID: 11157010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide.
    Ip EJ; Lee-Ma A; Troxell LS; Chan J
    Am J Health Syst Pharm; 2008 Aug; 65(16):1552-5. PubMed ID: 18693211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.
    Brito M; Esteves S; André R; Isidoro M; Moreira A
    Support Care Cancer; 2016 Feb; 24(2):597-603. PubMed ID: 26111956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma in an adolescent girl.
    Kannan R; Varma S; Ramprakash B; Nadaradjan S; Jeyaraman S; Sundararaman T; Sethuraman KR
    J Assoc Physicians India; 2001 Apr; 49():490-1. PubMed ID: 11762629
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
    Kushner BH; Heller G; Kramer K; Cheung NK
    Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy.
    Ishii E; Yoshida N; Miyazaki S
    Eur J Pediatr; 1984 Dec; 143(2):152-3. PubMed ID: 6519114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for breast cancer.
    Livi L; Meattini I; de Luca Cardillo C; Scotti V; Agresti B; Franzese C; Sanchez L; Nori J; Bertocci S; Cassani S; Bianchi S; Cataliotti L; Biti G
    J Chemother; 2011 Feb; 23(1):36-9. PubMed ID: 21482493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined chemotherapy with alpha interferon for neuroblastoma].
    Sawada J; Itoi T; Ishii K; Tanaka T; Matsumura T
    Gan To Kagaku Ryoho; 1984 May; 11(5):1147-9. PubMed ID: 6721514
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim.
    Ishiguro H; Kitano T; Yoshibayashi H; Toi M; Ueno T; Yasuda H; Yanagihara K; Garbo CL; Fukushima M
    Ann Oncol; 2008 May; 19(5):1019; author reply 1019-20. PubMed ID: 18325914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].
    Shida S; Arioka H; Hatayama Y; Nakadate H; Hatae Y; Takeda T
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):425-9. PubMed ID: 3348628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
    J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of G-CSF for breast cancer chemotherapy].
    Suzuki Y; Saito Y; Tokuda Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():572-4. PubMed ID: 17679213
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
    J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
    Park KH; Lee S; Park JH; Kang SY; Kim HY; Park IH; Park YH; Im YH; Lee HJ; Park S; Lee SI; Jung KH; Kim YS; Seo JH
    Support Care Cancer; 2017 Feb; 25(2):505-511. PubMed ID: 27709313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.